Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism

Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy. Hypocalcemia and gastrointestinal adverse reactions are the main side effects reported in patients treat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Endocrinol (Lausanne)
Asıl Yazarlar: Di Dalmazi, Giulia, Giuliani, Cesidio, Napolitano, Giorgio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2018
Konular:
Endocrinology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6308315/
https://ncbi.nlm.nih.gov/pubmed/30622514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00777
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller